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To the Editor:
CH, CH, CH, 1 : 2, 1: 2
The Usher syndromes (USHs; MIM 276900–276904,
601067, 60297, and 602083) are a group of autosomal
recessive hereditary disorders characterized by the as-
sociation of sensorineural hearing impairments and pro-
gressive visual loss due to retinitis pigmentosa. Three
types of USH are distinguished on the basis of severity
and onset of auditory and vestibulary dysfunctions. To
date, USHs are mapped to nine different genomic loci:
USH1A–F, USH2A, USH2B, and USH3 (Hereditary
Hearing Loss home page). USH3 (MIM 276902), as-
signed to chromosome 3q, is regarded as the rarest form
of USH (Sankilla et al. 1995)
The human myosin VIIA gene (MYO7A), located on
11q14, has been shown to be responsible for USH1B
(MIM 276903), which is the most common USH1 sub-
type, accounting for ∼75% of all type 1 cases (Weil et
al. 1995). More recently, MYO7A has also been shown
to be responsible for nonsyndromic recessive and dom-
inant deafness (DFNB2 and DFNA11), both types hav-
ing been assigned to the same 11q chromosomal region
(Liu et al. 1997a, 1997b; Weil et al. 1997). These find-
ings clearly indicate that the enzymatic activity of
MYO7A is critical for normal function in the inner ear
and that different mutations may cause different dys-
functions that are manifested by distinct phenotypes.
Here we report on two novel MYO7A mutations that
may have a synergistic effect on the symptoms of another
USH different from USH1B.
Among USH-affected families recruited as part of a
study on the genetics of USH, results of which were
published in this journal (Adato et al. 1997), was a non-
consanguineous family of Jewish Yemenite origin that
included two affected and six healthy siblings. The two
affected brothers in this family have different USH phe-
notypes. One of the affected brothers (1549 in fig. 1)
has a typical USH1 phenotype: he has a history of pre-
lingual profound auditory impairment; he uses sign lan-
guage for communication, since hearing aids are un-
helpful in his case; and developmental milestones (Smith
et al. 1994) in his childhood are consistent with con-
genital vestibular dysfunction. The other affected
brother (1636 in fig. 1) has a typical USH3 phenotype:
he has progressive hearing loss, with postlingual onset;
he uses hearing aids and verbal communication; and he
receives psychiatric therapy for mental problems. In both
affected brothers, the presence of bilateral progressive
pigmentary retinopathy has been diagnosed (with onset
during early adolescence).
Members of this family were typed for 30 polymor-
phic markers spanning all nine known USH loci
(USH1A-F, USH2A, USH2B, and USH3). Marker alleles
were identified and arranged into the most likely hap-
lotypes, as shown in figure 1. Haplotype segregation and
linkage analysis resulted in exclusion of all USH1 and
USH2 loci (LOD scores range from 1.46 to 3.72)
and suggested linkage only to the USH3 locus (with a
maximum LOD score of 1.35 for marker D3S1279).
Both affected brothers showed homozygosity for alleles
of four markers: D3S1315, D3S1279, D3S3625, and
D3S1294. Homozygosity of USH3 haplotypes in the af-
fected brothers—and the fact that, although not known
to be related, both parents originate from a small Jewish
community in Yemen—suggest a possible common or-
igin for both USH3-bearing chromosomes. This “USH3
haplotype” was found to be carried (one copy) by only
2 of 54 Jewish Yemenite control subjects tested for its
presence. The homozygote interval in both affected
brothers and the position of recombination in the pa-
ternal chromosome of one healthy progeny (1643; see
fig. 1) suggest that the USH3 gene is located between
markers D3S1299 and D3S3625. This result is in agree-
ment with the location suggested by Sankilla et al. (1995)
and by Joensuu et al. (1996). The order of markers span-
ning the USH3 linkage region, as presented in figure 1,
is cen, D3S2401, D3S1299, D3S1315, D3S1279,
D3S3625, D3S1594, tel, in agreement with the order
presented in the Whitehead contig (Whitehead Institute
for Biomedical Research). However, in this order, the
position of the markers D3S1315 and D3S1279, which
our findings indicated were the most closely linked to
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Figure 1 Genomic DNA extracted from blood of family members was used as a template for PCR amplification, which was done with
30 pairs of specific primers of markers spanning all nine USH loci. Marker alleles, identified according to their relative mobility on a denaturing
formamide 4% acrylamide gel in all family members, were arranged into the most likely haplotypes. This haplotype arrangement results in
exclusion of all USH1 and USH2 loci and suggests linkage only to the USH3 locus. Maternal chromosomes are gray and striped whereas
paternal chromosomes are white and dotted. Blackened squares on the gray USH1B maternal chromosomes indicate the presence of the mutated
MYO7A. The homozygote interval, of both affected brothers, in the USH3 locus is boxed.
USH3, differs from the one suggested by Joensuu et al.
(1996).
Since one of the affected brothers had an USH1 phe-
notype, family members were screened for mutations in
the human MYO7A gene, which has been shown to be
responsible for USH1B. Two new close nucleotide
changes were detected in exon 25 of the gene on one
maternal chromosome: a TrC transition and a guanine
deletion 5 nt upstream of this transition (fig. 2). None
of these changes were found in 1200 control chromo-
somes tested by allele-specific oligonucleotide analysis,
as described by Whithney et al. (1993). This mutated
MYO7A is carried by the brother with the USH1 phe-
notype (1549) but not by his affected brother with the
USH3 phenotype (1636). The mother (1637) and two
unaffected siblings (1638 and 1639), who are all double
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Figure 2 Comparative electrophoresis of normal (N) and mu-
tated (M) exon 25 PCR cycle-sequencing reaction, with SequiTherm
EXEL DNA Sequencing Kit (FMC). Products were electrophoresed
side by side through Long Ranger Gel (Epicentre Technologies):
ddGTP-terminated products of normal exon 25 appear next to ddGTP-
terminated products of mutated exon 25; and ddATP-terminated prod-
ucts of normal exon 25 appear next to ddATP-terminated products of
mutated exon 25. Arrows indicate the TrC transition and the guanine
deletion (5 nt up stream of the transition).
heterozygotes for the mutated MYO7A and for a single
USH3 haplotype, show no evidence of any USH symp-
toms or nonsyndromic deafness. This suggests a digenic
inheritance pattern, with a possible synergistic interac-
tion between MYO7A and the USH3 gene product,
where presence of a single defective MYO7A allele seems
to increase the severity of deafness as a part of the clinical
symptoms associated with USH3.
Evidence for digenic inheritance of nonsyndromic
deafness was already presented in the case of a Swedish
family (Balciuniene et al. 1998), whose affected members
were carriers of DFNA2 and/or DFNA12. Increased se-
verity of deafness was found in family members that
were carriers of both alleles. This clear additive effect
differs from the situation in our Yemenite family, where
mutated MYO7A appears to be phenotypically ex-
pressed only on the background of two defective USH3
alleles, suggesting an interaction between the MYO7A
and the USH3 gene products. Digenic inheritance was
also suggested as one of the possible explanations in the
case of DFNB15 (Chen et al. 1997). This is an autosomal
recessive nonsyndromic deafness, found in a family of
Indian origin, linked to two loci on chromosomes 3q
and 19p. Most interestingly in relation to our work, one
of these loci, 3q21.3-3q25.2, includes the USH3 locus
and the other, 19p13.3p13.1, includes (among others)
the MYO1F gene (Hasson et al. 1996), which is another
member of the unconventional myosin group.
Human MYO7A is a member of the unconventional
myosins group (Weil et al. 1996). All myosins have three
different functional domains defined within their heavy
chains: an N-terminal motor domain, a regulatory (light-
chain–binding) domain, and a tail domain that varies
dramatically in length and in sequence among myosins
(Mooseker and Cheney 1995). The functions of myosin-
tail domains are largely unknown. However, a common
assumption is that the tail directs the interaction of a
given myosin with its cargo (Mermall et al. 1998).
MYO7A is predicted to dimerize, on the basis of the
coiled-coil sequence motif at the start of its tail region.
The sequence changes detected in exon 25 of MYO7A
in some members of the presented family are expected
to result, at the protein level, in a LeurPro substitution
at codon 1087 and in a frameshift of the reading frame
starting at codon 1089. Both these AA codons are lo-
cated after the coiled-coil domain of the protein. This
frameshift would result in the formation of a UGA stop
codon 18 amino acids downstream from the deletion
site and, therefore, in the translation of a truncated pro-
tein that lacks 150% of its normal AA sequence, which
comprises most of the MYO7A tail domain. Segregation
of the mutated MYO7A with healthy members of this
family and, on the other hand, with the more severe
USH phenotype, suggests a possible biological interac-
tion between MYO7A and the USH3 gene products.
This mutated MYO7A appears to be phenotypically ex-
pressed only on the background of two USH3 alleles.
Many disease mutations that introduce stop codons
were found to lead to mRNA destabilization, as in the
mouse MYO6 sv allele (Avraham et al. 1995). In such
a case, segregation of the mutated MYO7A, as described
above, could indicate that the normal USH3 gene prod-
uct may affect the stabilization of the MYO7A mRNA
or the protein.
If the mutated MYO7A in this Yemenite family was
translated, then it would not lack its coiled-coil sequence
motif. Unlike the case of DFNB11, where a 9 bp deletion
in the coiled-coil region of MYO7A was suggested to
have a dominant negative effect (Liu et al. 1997b), seg-
regation of the mutated MYO7A with healthy members
of our family clearly determines the recessive nature of
its mutation. There are several possible explanations for
this difference. The truncated MYO7A produced in our
case may be incompetent for dimerization, since it is
unknown whether the remainder of the tail is required
for self assembly or if the truncated molecule may be
destabilized. Another possible reason is the formation
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of a partially functional heterodimer. These possibilities
would yield 50% of the normal protein amounts. In
any kind of direct or indirect USH3-MYO7A protein
interaction, a reduced-dosage effect of active MYO7A
protein is likely to have a synergistic effect on the back-
ground of the two impaired alleles of the USH3 gene
product.
One possible explanation for the USH3-MYO7A in-
teraction is that the USH3 protein might be involved in
targeting or binding MYO7A to the plasma membrane.
The tail of MYO7A consists of a direct repeat containing
two elements. The distal element, the talinlike domain,
shows significant homology to the N-terminus of talin
and limited homology to the N-termini of other members
of the band-4.1 superfamily of actin-binding proteins
(Weil et al. 1996; Chen et al. 1997). In talin and in band
4.1, this region binds to acidic phospholipids and me-
diates protein-protein interactions. Therefore, it is
thought that talinlike motifs serve to bind and/or target
the myosin to the plasma membrane (Cheney et al. 1993;
Titus et al. 1997).
It is also possible that USH3 is a cytoskeletal com-
ponent and as such interacts with the MYO7A protein:
Actin cytoskeleton is essential for proper the function of
the inner ear, and deafness-associated genes such as
MYO7A and MYO15 as well as the human diaphanous
protein are assumed to be cytoskeletal components (Vas-
iliki and Petit 1998).
The MYO7A protein may also serve an inner hair-
cell–specific role distinct from its role in actin. This role
might be complementary to the function of the USH3
gene product. For example, in mice, MYO7A was found
to be involved in hair-cell vesicle trafficking of amino-
glycosides, which are known to induce ototoxicity (Rich-
ardson et al. 1997).
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